No abstract

No abstract

Long-term mammary expression patterns of lipogenic gene networks due to dietary lipid remain largely unknown. Mammary tissue was biopsied for transcript profiling of 29 genes at 0, 7, and 21 days of feeding cows saturated lipid (EB100) or a blend of fish/soybean oil (FSO) to depress milk fat. Milk fat yield decreased gradually with FSO and coincided with lower molar yield of fatty acids synthesized de novo, stearic acid, and oleic acid. The PPARγ targets LPIN1 and SREBF1 along with ACSS2, ACACA, FASN, and LPL increased by day 7 of feeding EB100, but differences between diets disappeared by day 21. Expression of SCAP increased markedly over time with FSO and differed from EB100 by approximately sevenfold on day 21. Expression of THRSP decreased by day 7 with both diets and returned to basal levels by day 21. SCD expression increased linearly through 7 days and remained elevated with both diets, a likely mechanism to ensure the proper level of endogenous oleic acid via desaturation of dietary stearate (EB100) or via more SCD protein to account for the reduction in stearate supply from the rumen (FSO). Despite this response, endogenous oleate was insufficient to restore normal milk fat synthesis. Only 2 of 29 genes differed in expression between diets on day 21, suggesting that transcriptional control mechanisms regulating fat synthesis were established as early as 7 days post-feeding. Gene expression reflected vastly different physiological responses by mammary tissue to adjust its metabolism to the influx of saturated fatty acids, trans10-18:1, and/or to the lack of stearic acid.

Synthetic Biology (SynBio) is an interdisciplinary field at the interface of engineering and biology aiming to develop new biological systems and impart new functions to living cells. EFSA has been asked by the European Commission to evaluate SynBio developments in agri‐food with the aim of identifying the adequacy of existing guidelines for risk assessment and determine if updated guidance is needed. The scope of this opinion covers the molecular characterisation and environmental risk assessment of such genetically modified plants obtained through SynBio, meant to be for cultivation or food and feed purposes. The previous work on SynBio by the non‐food scientific Committees (2014, 2015) was used and complemented with the output of a horizon scanning exercise, which was commissioned by the EFSA to identify the most realistic and forthcoming SynBio cases of relevance to this remit. The horizon scan did not identify other sectors/advances in addition to the six SynBio categories previously identified by the non‐food scientific committees of the European Commission. The exercise did show that plant SynBio products reaching the market in the near future (next decade) are likely to apply SynBio approaches to their development using existing genetic modification and genome editing technologies. In addition, three hypothetical SynBio case studies were selected by the working group of the Panel on Genetically Modified Organisms (GMO), to further support the scoping exercise of this Scientific Opinion. Using the selected cases, the GMO Panel concludes that the requirements of the EU regulatory framework and existing EFSA guidelines are adequate for the risk assessment of SynBio products to be developed in the next 10 years, although specific requirements may not apply to all products. The GMO Panel acknowledges that as SynBio developments evolve, a need may exist to adjust the guidelines to ensure they are adequate and sufficient.

The aim of this study was to evaluate the bioavailability of ingested selenium (Se) yeast in laying hens and its effects on performance, eggshell quality, and tissue Se distribution. Forty-eight ISA brown laying hens were divided into 3 treatment groups: Group C, fed a basal diet containing 0.11 mg Se/kg of feed; Group SS, fed a basal diet plus 0.4 mg/kg of feed of Se from sodium selenite; and Group SY, fed a basal diet plus 0.4 mg/kg of feed of Se from selenium yeast. Feed intake, egg mass ratio, and production performance were not affected by Se supplementation, regardless of the Se source. Egg weight (+3.61% and +2.95%), eggshell weight (+4.26% and +5.38%), and eggshell surface (+2.43% and +1.96%) were higher (P<0.05) in SS and SY than C, whereas breaking strength was increased in SY (P<0.01). Breast muscle, liver and skin Se levels were higher in SY than in C, while kidney Se content was higher in SS hens. Eggs from SY had higher Se levels than SS. Blood metabolites were not affected in SS or SY groups than C. A higher Se level was detected in eggs and breast muscle of SY hens (P<0.05). Seleniumenriched eggs and edible tissues from organic Se sources in poultry diet could improve antioxidant status in humans and reduce possible Se deficiency-related diseases.